Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Tech-Driven Pharma Company TrialSpark Secures $156 Million In Series C Funding – Pulse 2.0,

TrialSpark’s thesis is that in today’s world — where the long and expensive clinical trial process is the biggest bottleneck in drug development — the …, TrialSpark’s thesis is that in today’s world — where the long and expensive clinical trial process is the biggest bottleneck in drug development — the …, Read More

Scroll to Top